Gallop, Lucy, Westwood, Samuel J, Hemmings, Amelia, Lewis, Yael, Campbell, Iain C and Schmidt, Ulrike 2024. Effects of repetitive transcranial magnetic stimulation in children and young people with psychiatric disorders: a systematic review. European Child & Adolescent Psychiatry. Advanced online publication. https://doi.org/10.1007/s00787-024-02475-x
| Title | Effects of repetitive transcranial magnetic stimulation in children and young people with psychiatric disorders: a systematic review. |
|---|---|
| Type | Journal article |
| Authors | Gallop, Lucy, Westwood, Samuel J, Hemmings, Amelia, Lewis, Yael, Campbell, Iain C and Schmidt, Ulrike |
| Abstract | Repetitive transcranial magnetic stimulation (rTMS) has demonstrated benefits in adults with psychiatric disorders, but its clinical utility in children and young people (CYP) is unclear. This PRISMA systematic review used published and ongoing studies to examine the effects of rTMS on disorder-specific symptoms, mood and neurocognition in CYP with psychiatric disorders. We searched Medline via PubMed, Embase, PsychINFO via OVID, and Clinicaltrials.gov up to July 2023. Eligible studies involved multiple-session (i.e., treatment) rTMS in CYP (≤ 25 years-old) with psychiatric disorders. Two independent raters assessed the eligibility of studies and extracted data using a custom-built form. Out of 78 eligible studies (participant N = 1389), the majority (k = 54; 69%) reported an improvement in at least one outcome measure of disorder-specific core symptoms. Some studies (k = 21) examined rTMS effects on mood or neurocognition,: findings were largely positive. Overall, rTMS was well-tolerated with minimal side-effects. Of 17 ongoing or recently completed studies, many are sham-controlled RCTs with better blinding techniques and a larger estimated participant enrolment. Findings provide encouraging evidence for rTMS-related improvements in disorder-specific symptoms in CYP with different psychiatric disorders. However, in terms of both mood (for conditions other than depression) and neurocognitive outcomes, evidence is limited. Importantly, rTMS is well-tolerated and safe. Ongoing studies appear to be of improved methodological quality; however, future studies should broaden outcome measures to more comprehensively assess the effects of rTMS and develop guidance on dosage (i.e., treatment regimens). [Abstract copyright: © 2024. The Author(s).] |
| Keywords | rTMS |
| Children | |
| Psychiatric disorders | |
| Systematic review | |
| Young people | |
| Journal | European Child & Adolescent Psychiatry |
| ISSN | 1435-165X |
| Year | 2024 |
| Publisher | Springer Nature |
| Publisher's version | License CC BY 4.0 File Access Level Open (open metadata and files) |
| Digital Object Identifier (DOI) | https://doi.org/10.1007/s00787-024-02475-x |
| PubMed ID | 38809301 |
| Publication dates | |
| Published online | 29 May 2024 |
| Project | MR/W002418/1 |
| Funder | MRC/AHRC/ESRC Adolescence, Mental Health and the Developing Mind initiative |